Atlas Trials

Phase 2 Study to Determine if RTB101 Reduces the Severity of COVID-19 in Older Adults Residing in Nursing Homes

Clinical trial NCT04409327 · TERMINATED

Trial details

NCT number
NCT04409327
Sponsor
Restorbio Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
COVID19
Start date
2020-07-11
Primary completion
2020-12-27
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.